Offer - Urjas Oil for just ₹ 1 X
Lobet Injection, a prescription drug, is manufactured in various forms such as Injection. High BP are some of its major therapeutic uses. Lobet Injection also has some secondary and off-label uses. These are listed below.
The optimal dosage of Lobet Injection is largely dependent on the individual's body weight, medical history, gender and age. The condition it has been prescribed for, and the route of administration also determine the right dosage. Detailed information has been provided in the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Lobet Injection as well, which are listed below. Usually, these side effects of Lobet Injection go away soon, and do not persist beyond the duration of the treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
In addition, Lobet Injection's effect is Severe during pregnancy and Mild for lactating mothers. In addition, Lobet Injection's effects on the liver, heart and kidney are discussed below in the Lobet Injection related warnings section.
Lobet Injection is contraindicated in people with pre-existing medical conditions like Diabetes, Asthma, COPD (Chronic Obstructive Pulmonary Disease) as it can result in adverse effects. The section on Lobet Injection contraindications lists all such conditions.
Additionally, Lobet Injection may also adversely react with other medicines. A complete list of these interactions is given below.
Along with the above-mentioned precautions, remember that taking Lobet Injection is considered not safe while driving, and is not addictive.
Lobet Injection is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Geriatric |
|
Adult |
|
Is the use of Lobet Injection safe for pregnant women?
Pregnant women may get severe side effects after taking Lobet. If you are pregnant, do not take Lobet without a doctor's advice.
Is the use of Lobet Injection safe during breastfeeding?
Side effects of Lobet for breastfeeding are little to none, so you can take it without doctor's advice.
What is the effect of Lobet Injection on the Kidneys?
Lobet is completely safe for kidneys.
What is the effect of Lobet Injection on the Liver?
Lobet may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Lobet Injection on the Heart?
Lobet is rarely harmful for the heart.
If you are suffering from any of the following diseases, you should not take Lobet Injection unless your doctor advises you to do so -
Is this Lobet Injection habit forming or addictive?
No, there is no any evidence that Lobet Injection is addictive.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Lobet Injection as you may feel sleepy.
Is it safe?
Yes, Lobet Injection is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
No, the use of Lobet Injection in mental disorders is not effective.
Interaction between Food and Lobet Injection
Some foods when eaten with Lobet Injection can alter the onset of actions. Discuss this with your doctor.
Interaction between Alcohol and Lobet Injection
Taking Lobet Injection with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Trandate® (labetalol hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 151
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 735-737